Julie Zhou

1.2k total citations
67 papers, 809 citations indexed

About

Julie Zhou is a scholar working on Management Science and Operations Research, Computational Theory and Mathematics and Statistics and Probability. According to data from OpenAlex, Julie Zhou has authored 67 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Management Science and Operations Research, 22 papers in Computational Theory and Mathematics and 20 papers in Statistics and Probability. Recurrent topics in Julie Zhou's work include Optimal Experimental Design Methods (28 papers), Advanced Multi-Objective Optimization Algorithms (20 papers) and Advanced Statistical Methods and Models (18 papers). Julie Zhou is often cited by papers focused on Optimal Experimental Design Methods (28 papers), Advanced Multi-Objective Optimization Algorithms (20 papers) and Advanced Statistical Methods and Models (18 papers). Julie Zhou collaborates with scholars based in Canada, United States and China. Julie Zhou's co-authors include Xiaogang Li, Xiaoyan Li, James P. Calvet, Douglas P. Wiens, Jane J. Ye, Hongtu Zhu, Fangliang He, Lucy X. Fan, Christian Janßen and Bo Söderberg and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American Statistical Association and PLoS ONE.

In The Last Decade

Julie Zhou

64 papers receiving 785 citations

Peers

Julie Zhou
Chris Harbron United Kingdom
Nicolas Frey Switzerland
Beatrix Jones New Zealand
Kay Tatsuoka United States
Saumyadipta Pyne United States
Rui Qin United States
Chris Harbron United Kingdom
Julie Zhou
Citations per year, relative to Julie Zhou Julie Zhou (= 1×) peers Chris Harbron

Countries citing papers authored by Julie Zhou

Since Specialization
Citations

This map shows the geographic impact of Julie Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Zhou more than expected).

Fields of papers citing papers by Julie Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Zhou. The network helps show where Julie Zhou may publish in the future.

Co-authorship network of co-authors of Julie Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Zhou. A scholar is included among the top collaborators of Julie Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Zhou. Julie Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wu, Jiao, Alice Cheng, Thomas Weimbs, et al.. (2025). GLP1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis. The FASEB Journal. 39(16). e70944–e70944. 1 indexed citations
4.
Zhou, Julie, Costas Mitsopoulos, & Olivia W. Rossanese. (2024). Abstract A021: Hunting for synthetic lethal partners in DNA damage response-altered endometrial cancer. Molecular Cancer Therapeutics. 23(6_Supplement). A021–A021. 1 indexed citations
5.
Agborbesong, Ewud, Julie Zhou, Hongbing Zhang, et al.. (2024). Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability. Biomedicines. 12(3). 603–603. 5 indexed citations
6.
Zhou, Julie, Xiaoyan Li, Hongbing Zhang, et al.. (2024). DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. Kidney International. 106(2). 258–272. 4 indexed citations
7.
Zhou, Julie, Alice Cheng, Li Chen, et al.. (2024). CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease. Cells. 13(6). 489–489. 6 indexed citations
8.
Zhou, Julie & Vicente E. Torres. (2023). Drug repurposing in autosomal dominant polycystic kidney disease. Kidney International. 103(5). 859–871. 18 indexed citations
9.
Zhang, Lu, Hongbing Zhang, Ewud Agborbesong, Julie Zhou, & Xiaogang Li. (2023). Phosphorylation of MIF by PIP4K2a is necessary for cilia biogenesis. Cell Death and Disease. 14(12). 795–795. 6 indexed citations
10.
Zhou, Julie & Vicente E. Torres. (2023). Autosomal Dominant Polycystic Kidney Disease Therapies on the Horizon. PubMed. 30(3). 245–260. 6 indexed citations
11.
Agborbesong, Ewud, et al.. (2022). Prdx5 regulates DNA damage response through autophagy-dependent Sirt2-p53 axis. Human Molecular Genetics. 32(4). 567–579. 9 indexed citations
12.
Zhou, Julie, Brenda S. Magenheimer, Gail A. Reif, et al.. (2022). The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease. American Journal of Physiology-Renal Physiology. 323(4). F492–F506. 1 indexed citations
13.
Yu, Wenyan, Xiaoyan Li, Hongbing Zhang, et al.. (2022). Transcription factor FoxM1 promotes cyst growth in PKD1 mutant ADPKD. Human Molecular Genetics. 32(7). 1114–1126. 6 indexed citations
14.
Li, Xiaoyan, Lu Zhang, Ewud Agborbesong, et al.. (2022). Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease. American Journal of Physiology-Renal Physiology. 323(2). F227–F242. 14 indexed citations
15.
Wong, Weng Kee & Julie Zhou. (2022). Using CVX to Construct Optimal Designs for Biomedical Studies with Multiple Objectives. Journal of Computational and Graphical Statistics. 32(2). 744–753. 7 indexed citations
16.
Li, Xiaoyan, Julie Zhou, Hongbing Zhang, et al.. (2020). Cross-talk between CDK4/6 and SMYD2 regulates gene transcription, tubulin methylation, and ciliogenesis. Science Advances. 6(44). 32 indexed citations
17.
Zhang, Lu, Xiaoyan Li, Julie Zhou, et al.. (2020). RNA helicase p68 inhibits the transcription and post-transcription of Pkd1 in ADPKD. Theranostics. 10(18). 8281–8297. 20 indexed citations
18.
Zhou, Julie, et al.. (2015). TNFα Signaling Regulates Cystic Epithelial Cell Proliferation through Akt/mTOR and ERK/MAPK/Cdk2 Mediated Id2 Signaling. PLoS ONE. 10(6). e0131043–e0131043. 22 indexed citations
19.
Edwards, Roderick, et al.. (2015). Robust designs for experiments with blocks. Communication in Statistics- Theory and Methods. 45(18). 5363–5379.
20.
Zhou, Julie. (2001). INTEGER-VALUED, MINIMAX ROBUST DESIGNS FOR APPROXIMATELY LINEAR MODELS WITH CORRELATED ERRORS. Communication in Statistics- Theory and Methods. 30(1). 21–39. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026